Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2011 Apr;84(4):517-31.
doi: 10.4269/ajtmh.2011.10-0285.

Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis

Kathrine R Tan  1 , Alan J Magill, Monica E Parise, Paul M Arguin; Centers for Disease Control and Prevention
Affiliations
Practice Guideline

Doxycycline for malaria chemoprophylaxis and treatment: report from the CDC expert meeting on malaria chemoprophylaxis

Kathrine R Tan et al. Am J Trop Med Hyg. 2011 Apr.

Abstract

Doxycycline, a synthetically derived tetracycline, is a partially efficacious causal prophylactic (liver stage of Plasmodium) drug and a slow acting blood schizontocidal agent highly effective for the prevention of malaria. When used in conjunction with a fast acting schizontocidal agent, it is also highly effective for malaria treatment. Doxycycline is especially useful as a prophylaxis in areas with chloroquine and multidrug-resistant Plasmodium falciparum malaria. Although not recommended for pregnant women and children < 8 years of age, severe adverse events are rarely reported for doxycycline. This report examines the evidence behind current recommendations for the use of doxycycline for malaria and summarizes the available literature on its safety and tolerability.

PubMed Disclaimer

References

    1. Centers for Disease Control and Prevention . CDC Health Information for International Travel 2010. Atlanta, GA: Elsevier; 2009.
    1. Griffith KS, Lewis LS, Mali S, Parise ME. Treatment of malaria in the United States: a systematic review. JAMA. 2007;297:2264–2277. - PubMed
    1. McEvoy G, editor. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, Inc; 2008. (Tetracyclines).
    1. Rieckmann KH, McNamara JV, Willerson D, Kass L, Frischer J, Carson PE. Effects of tetracycline against chloroquineresistant and cloroquine-sensitive Plasmodium falcuparum. Am J Trop Med Hyg. 1971;20:811–815. - PubMed
    1. Clyde DF, DuPont HL, Hornick RB. Antimalarial effects of tetracyclines in man. J Trop Med Hyg. 1971;74:238–242. - PubMed

Publication types